Search results (77)
« Back to NewsFuture of Chair in Global Health secured with £5 million gift
20 September 2023
Awards & Appointments Department Research Teaching University
The University of Oxford’s commitment to tackling major global health challenges has been strengthened following the endowment of a chair in global health and clinical development. The new permanent post was made possible by a £5 million donation from Brazilian healthcare organisation SAIL for Health.
Anindita Roy appointed Professor of Paediatric Haematology
13 September 2023
Awards & Appointments Haematology Research Teaching University
The Department of Paediatrics at the University of Oxford is delighted to announce that Anindita Roy has been named Professor of Paediatric Haematology at the University of Oxford.
First in-human trials commence for CCHF vaccine
12 September 2023
COVID-19 Clinical Trials Research Vaccinology
A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to human volunteers for the first time. The clinical trial of the ChAdOx2 CCHF vaccine aims to confirm its safety and understand how individuals develop immunity following vaccination.
University of Oxford partners with CEPI to counter the threat of future pandemics
31 August 2023
COVID-19 Research University Vaccinology
The University of Oxford and the Coalition for Epidemic Preparedness Innovations (CEPI) have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.
New study to test babies for Spinal Muscular Atrophy
30 August 2023
Children's Health Clinical Trials Neuromuscular Diseases Research
Scientists at the University of Oxford are running a study at participating hospitals in the Thames Valley and Wessex regions, offering parents the ability to have their newborn baby’s blood tested for Spinal Muscular Atrophy (SMA), in addition to the nine other conditions that are already tested for.
Oxford gets £122m funding for healthcare research
19 October 2022
Awards & Appointments Research
Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. The funding was awarded to the two NIHR Biomedical Research Centres.
Study raises hope of pre-school type 1 diabetes screening programme
6 September 2022
Researchers in Oxford have launched the first UK study in the general population to test for early markers of type 1 diabetes before children develop symptoms or need insulin.
Angelman syndrome: first patient to receive potential therapy in Oxford
3 December 2021
Neuromuscular Diseases Research
Things that seemed impossible, only a few years ago, are happening today. The first patient in Europe and one of the first in the world was injected with a potential treatment, GTX-102, in a phase I/II clinical trial in Oxford.
New model for infant leukaemia announced
25 November 2021
Haematology Publication Research
The breakthrough could lead to development of new treatments for infant Acute Lymphoblastic Leukaemia.
Why it's so hard to treat pain in infants
12 November 2021
Children's Health Neuroimaging Research
For decades physicians believed that premature babies didn’t experience pain. Here’s what doctors know now – and the innovative solutions being embraced by today's caregivers.
Oxford to work with Brazil to establish clinical research hub
8 November 2021
The University of Oxford and Brazilian Ministry of Health have announced a joint initiative to set up a global health and clinical research unit in Brazil led by Professor Sue Ann Clemens CBE.
New atlas revealed of bone marrow haematopoiesis during development
5 October 2021
Children's Health Haematology Immunology Research
A new study published this week in Nature, provides the most detailed analysis so far of the prenatal development of blood and immune cells in the bone marrow.
Promising discovery for treatment of neuromuscular diseases
23 August 2021
Neuromuscular Diseases Publication Research
Research led by Carlo Rinaldi and Catheryn Lim discovered that a naturally-occurring isoform of an androgen receptor can be used in therapy for spinal and bulbar muscular atrophy, and shows potential for other diseases.
University of Oxford researchers among recipients of Ireland and UK joint research awards for digital humanities in €6.5m boost for interdisciplinary research partnerships
9 August 2021
Awards & Appointments Research
Dr Samantha Vanderslott (Oxford Vaccine Group) and Dr Claas Kirchhelle (University College Dublin) have had their three-year project ‘Typhoid, Cockles, and Terrorism’ about the history of typhoid in Dublin successfully funded.
Increasing vaccine uptake among ethnic minorities
6 May 2021
COVID-19 Public Engagement Research Vaccinology
Dr Samantha Vanderslott and Dr Seilesh Kadambari discuss their collaborative approach to providing ethnic minority groups with information on vaccines.
Innovation award for Paediatrics researcher to develop new treatments for childhood cancer
18 March 2021
Awards & Appointments Haematology Research
Associate Professor Andi Roy leads one of the five research teams across the UK that have been awarded the 2021 Cancer Research UK-Children with Cancer UK Innovation Award. The awards, which provide a total of £4.3 million in scientific funding, will allow leading researchers in the field to delve into the biology of children’s and young people’s cancers, with the hope of finding new ways to prevent and treat these complex cancers.
Celebrating Early Careers Researchers on International Women's Day
8 March 2021
In these short interviews, Anna Kordala and Jane Millar talk about the research they do at the Department of Paediatrics.
Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests
24 February 2021
The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.
Oxford vaccine effective against major B.1.1.7 ‘Kent’ coronavirus strain circulating in the UK
5 February 2021
A preprint of ongoing work to assess effectiveness of Oxford’s ChAdOx1 coronavirus vaccine shows that the existing vaccine has similar efficacy against the B.1.1.7 ‘Kent’ coronavirus strain currently circulating in the UK to previously circulating variants.